Scarica l'app Stockscreener
3.51
3.85%
0.13
Dopo l'orario di chiusura:
3.51
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors - Lelezard
GoodRx Holdings (NasdaqGS:GDRX) Stock Forecast & Analyst Predictions - Simply Wall Street
GoodRx CFO Justin Fengler Reports RSU Vesting and Share Withholding on September 15, 2026 - Kalkine Media
GoodRx CAO Thomas Chan Reports RSU Vesting and Tax-Related Share Withholding on September 15, 2026 - Kalkine Media
GoodRx (GDRX) exec converts RSUs and withholds shares for taxes - Stock Titan
GoodRX’s $32 Million Data-Sharing Settlement Wins Initial Nod - Bloomberg Law News
AIAI Stock Price, Quote & News - Syfe
TaskUs, Inc. Class A (TASK) Stock Price & News - Syfe
InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - Investing.com Australia
InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - investing.com
GoodRx offers health subscription for families, to launch as employee benefit in 2027 - reuters.com
GDRX Looks 34.8% Undervalued on GF Value™ - GuruFocus
One plan covers kids, adults and pets. GoodRx's new membership costs $24.99 a month. - Stock Titan
Promising Penny Stocks To Consider In August 2026 - simplywall.st
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX) - The Globe and Mail
GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com Nigeria
GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com India
Major GoodRx (NASDAQ: GDRX) holder reshapes stake via conversion and sale - Stock Titan
GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com
GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Moomoo
GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Quiver Quantitative
GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingROE Trend Analysis - vinanet.vn
GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingProfit Announcement - vinanet.vn
GoodRx 10% owner Francisco Partners sells $4.2m in shares By Investing.com - Investing.com Australia
GoodRx 10% owner Francisco Partners sells $4.2m in shares By Investing.com - Investing.com India
GDRX Maintains Underweight Rating -- Price Target Raised to $4.0 - GuruFocus
Q2 2026 GoodRx Holdings, Inc. Earnings Call Transcript - GuruFocus
GoodRx 10% owner Francisco Partners sells $4.2m in shares - Investing.com
GoodRx(GDRX.US) 10% Shareholder Sells US$4.2 Million in Common Stock - Moomoo
Justin Fengler Net Worth (2026) - GuruFocus
Big GoodRx (NASDAQ: GDRX) backer prepares share sale - Stock Titan
Technology Crossover Management X Ltd. Buys Shares of 1,653,566 GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move: Shares Move Lower 1.88% in Latest TradingShare Repurchase Impact - siam.in
GoodRx Holdings Inc (GDRX) (Q2 2026) Earnings Call Highlights: R - GuruFocus
GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
GDRX Maintained by UBS -- Price Target Raised to $3.75 - GuruFocus
GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook - Yahoo Finance
GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise - Yahoo Finance
GoodRx (GDRX) Stock Trades At A Premium On Earnings Despite Weak Returns - webull.com
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - The Motley Fool
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - AOL.com
GoodRx (NASDAQ:GDRX) Trading Down 5.1%What's Next? - MarketBeat
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope (NASDAQ:GDRX) - Seeking Alpha
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - The Globe and Mail
GDRX Maintained by Citigroup -- Price Target Raised to $5.00 - GuruFocus
2.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):